English
简体中文
Total: £ 56.28
Published Date: 2025-07-16 | Pages: 94 | Tables: 93 | Medical Care
The global market for Peptide CRDMO was valued at US$ 3810 million in the year 2024 and is projected to reach a revised size of US$ 8475 million by 2031, growing at a CAGR of 12.1% during the forecast period.
Peptide CRDMO is a service model that integrates contract research, process development and GMP production, focusing on providing end-to-end solutions for peptide drugs from preclinical research, process scale-up to commercial manufacturing. Its services cover solid phase/liquid phase synthesis, modification, purification, analytical method development and validation, clinical sample preparation, CMC document support, etc. of peptides, helping customers to efficiently advance project progress, control costs and comply with regulations of various countries.
North American market for Peptide CRDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Peptide CRDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Peptide CRDMO in Pharmaceuticals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Peptide CRDMO include Bachem, PolyPeptide, Ambio, USV Peptide, BCNpeptides, Lonza, CordenPharma, PeptiDream, AmbioPharm, CPC Scientific, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Peptide CRDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide CRDMO.
The Peptide CRDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide CRDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide CRDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bachem
PolyPeptide
Ambio
USV Peptide
BCNpeptides
Lonza
CordenPharma
PeptiDream
AmbioPharm
CPC Scientific
Sinopep
SynZeal
Cambrex Corporation
Tide Pharmaceutical
Hybio Pharmaceutical
Rochi Pharma
Segment by Type
Solid‑Phase Peptide Synthesis
Liquid‑Phase Peptide Synthesis
Segment by Application
Pharmaceuticals
Scientific Research
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide CRDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide CRDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Solid‑Phase Peptide Synthesis
1.2.3 Liquid‑Phase Peptide Synthesis
1.3 Market by Application
1.3.1 Global Peptide CRDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceuticals
1.3.3 Scientific Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide CRDMO Market Perspective (2020-2031)
2.2 Global Peptide CRDMO Growth Trends by Region
2.2.1 Global Peptide CRDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Peptide CRDMO Historic Market Size by Region (2020-2025)
2.2.3 Peptide CRDMO Forecasted Market Size by Region (2026-2031)
2.3 Peptide CRDMO Market Dynamics
2.3.1 Peptide CRDMO Industry Trends
2.3.2 Peptide CRDMO Market Drivers
2.3.3 Peptide CRDMO Market Challenges
2.3.4 Peptide CRDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide CRDMO Players by Revenue
3.1.1 Global Top Peptide CRDMO Players by Revenue (2020-2025)
3.1.2 Global Peptide CRDMO Revenue Market Share by Players (2020-2025)
3.2 Global Top Peptide CRDMO Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Peptide CRDMO Revenue
3.4 Global Peptide CRDMO Market Concentration Ratio
3.4.1 Global Peptide CRDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide CRDMO Revenue in 2024
3.5 Global Key Players of Peptide CRDMO Head office and Area Served
3.6 Global Key Players of Peptide CRDMO, Product and Application
3.7 Global Key Players of Peptide CRDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide CRDMO Breakdown Data by Type
4.1 Global Peptide CRDMO Historic Market Size by Type (2020-2025)
4.2 Global Peptide CRDMO Forecasted Market Size by Type (2026-2031)
5 Peptide CRDMO Breakdown Data by Application
5.1 Global Peptide CRDMO Historic Market Size by Application (2020-2025)
5.2 Global Peptide CRDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Peptide CRDMO Market Size (2020-2031)
6.2 North America Peptide CRDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Peptide CRDMO Market Size by Country (2020-2025)
6.4 North America Peptide CRDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide CRDMO Market Size (2020-2031)
7.2 Europe Peptide CRDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Peptide CRDMO Market Size by Country (2020-2025)
7.4 Europe Peptide CRDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Peptide CRDMO Market Size (2020-2031)
8.2 Asia-Pacific Peptide CRDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Peptide CRDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific Peptide CRDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Peptide CRDMO Market Size (2020-2031)
9.2 Latin America Peptide CRDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Peptide CRDMO Market Size by Country (2020-2025)
9.4 Latin America Peptide CRDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide CRDMO Market Size (2020-2031)
10.2 Middle East & Africa Peptide CRDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Peptide CRDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa Peptide CRDMO Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bachem
11.1.1 Bachem Company Details
11.1.2 Bachem Business Overview
11.1.3 Bachem Peptide CRDMO Introduction
11.1.4 Bachem Revenue in Peptide CRDMO Business (2020-2025)
11.1.5 Bachem Recent Development
11.2 PolyPeptide
11.2.1 PolyPeptide Company Details
11.2.2 PolyPeptide Business Overview
11.2.3 PolyPeptide Peptide CRDMO Introduction
11.2.4 PolyPeptide Revenue in Peptide CRDMO Business (2020-2025)
11.2.5 PolyPeptide Recent Development
11.3 Ambio
11.3.1 Ambio Company Details
11.3.2 Ambio Business Overview
11.3.3 Ambio Peptide CRDMO Introduction
11.3.4 Ambio Revenue in Peptide CRDMO Business (2020-2025)
11.3.5 Ambio Recent Development
11.4 USV Peptide
11.4.1 USV Peptide Company Details
11.4.2 USV Peptide Business Overview
11.4.3 USV Peptide Peptide CRDMO Introduction
11.4.4 USV Peptide Revenue in Peptide CRDMO Business (2020-2025)
11.4.5 USV Peptide Recent Development
11.5 BCNpeptides
11.5.1 BCNpeptides Company Details
11.5.2 BCNpeptides Business Overview
11.5.3 BCNpeptides Peptide CRDMO Introduction
11.5.4 BCNpeptides Revenue in Peptide CRDMO Business (2020-2025)
11.5.5 BCNpeptides Recent Development
11.6 Lonza
11.6.1 Lonza Company Details
11.6.2 Lonza Business Overview
11.6.3 Lonza Peptide CRDMO Introduction
11.6.4 Lonza Revenue in Peptide CRDMO Business (2020-2025)
11.6.5 Lonza Recent Development
11.7 CordenPharma
11.7.1 CordenPharma Company Details
11.7.2 CordenPharma Business Overview
11.7.3 CordenPharma Peptide CRDMO Introduction
11.7.4 CordenPharma Revenue in Peptide CRDMO Business (2020-2025)
11.7.5 CordenPharma Recent Development
11.8 PeptiDream
11.8.1 PeptiDream Company Details
11.8.2 PeptiDream Business Overview
11.8.3 PeptiDream Peptide CRDMO Introduction
11.8.4 PeptiDream Revenue in Peptide CRDMO Business (2020-2025)
11.8.5 PeptiDream Recent Development
11.9 AmbioPharm
11.9.1 AmbioPharm Company Details
11.9.2 AmbioPharm Business Overview
11.9.3 AmbioPharm Peptide CRDMO Introduction
11.9.4 AmbioPharm Revenue in Peptide CRDMO Business (2020-2025)
11.9.5 AmbioPharm Recent Development
11.10 CPC Scientific
11.10.1 CPC Scientific Company Details
11.10.2 CPC Scientific Business Overview
11.10.3 CPC Scientific Peptide CRDMO Introduction
11.10.4 CPC Scientific Revenue in Peptide CRDMO Business (2020-2025)
11.10.5 CPC Scientific Recent Development
11.11 Sinopep
11.11.1 Sinopep Company Details
11.11.2 Sinopep Business Overview
11.11.3 Sinopep Peptide CRDMO Introduction
11.11.4 Sinopep Revenue in Peptide CRDMO Business (2020-2025)
11.11.5 Sinopep Recent Development
11.12 SynZeal
11.12.1 SynZeal Company Details
11.12.2 SynZeal Business Overview
11.12.3 SynZeal Peptide CRDMO Introduction
11.12.4 SynZeal Revenue in Peptide CRDMO Business (2020-2025)
11.12.5 SynZeal Recent Development
11.13 Cambrex Corporation
11.13.1 Cambrex Corporation Company Details
11.13.2 Cambrex Corporation Business Overview
11.13.3 Cambrex Corporation Peptide CRDMO Introduction
11.13.4 Cambrex Corporation Revenue in Peptide CRDMO Business (2020-2025)
11.13.5 Cambrex Corporation Recent Development
11.14 Tide Pharmaceutical
11.14.1 Tide Pharmaceutical Company Details
11.14.2 Tide Pharmaceutical Business Overview
11.14.3 Tide Pharmaceutical Peptide CRDMO Introduction
11.14.4 Tide Pharmaceutical Revenue in Peptide CRDMO Business (2020-2025)
11.14.5 Tide Pharmaceutical Recent Development
11.15 Hybio Pharmaceutical
11.15.1 Hybio Pharmaceutical Company Details
11.15.2 Hybio Pharmaceutical Business Overview
11.15.3 Hybio Pharmaceutical Peptide CRDMO Introduction
11.15.4 Hybio Pharmaceutical Revenue in Peptide CRDMO Business (2020-2025)
11.15.5 Hybio Pharmaceutical Recent Development
11.16 Rochi Pharma
11.16.1 Rochi Pharma Company Details
11.16.2 Rochi Pharma Business Overview
11.16.3 Rochi Pharma Peptide CRDMO Introduction
11.16.4 Rochi Pharma Revenue in Peptide CRDMO Business (2020-2025)
11.16.5 Rochi Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Peptide CRDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Solid‑Phase Peptide Synthesis
Table 3. Key Players of Liquid‑Phase Peptide Synthesis
Table 4. Global Peptide CRDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Peptide CRDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Peptide CRDMO Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Peptide CRDMO Market Share by Region (2020-2025)
Table 8. Global Peptide CRDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Peptide CRDMO Market Share by Region (2026-2031)
Table 10. Peptide CRDMO Market Trends
Table 11. Peptide CRDMO Market Drivers
Table 12. Peptide CRDMO Market Challenges
Table 13. Peptide CRDMO Market Restraints
Table 14. Global Peptide CRDMO Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Peptide CRDMO Market Share by Players (2020-2025)
Table 16. Global Top Peptide CRDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide CRDMO as of 2024)
Table 17. Ranking of Global Top Peptide CRDMO Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Peptide CRDMO Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Peptide CRDMO, Headquarters and Area Served
Table 20. Global Key Players of Peptide CRDMO, Product and Application
Table 21. Global Key Players of Peptide CRDMO, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Peptide CRDMO Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Peptide CRDMO Revenue Market Share by Type (2020-2025)
Table 25. Global Peptide CRDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Peptide CRDMO Revenue Market Share by Type (2026-2031)
Table 27. Global Peptide CRDMO Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Peptide CRDMO Revenue Market Share by Application (2020-2025)
Table 29. Global Peptide CRDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Peptide CRDMO Revenue Market Share by Application (2026-2031)
Table 31. North America Peptide CRDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Peptide CRDMO Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Peptide CRDMO Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Peptide CRDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Peptide CRDMO Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Peptide CRDMO Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Peptide CRDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Peptide CRDMO Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Peptide CRDMO Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Peptide CRDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Peptide CRDMO Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Peptide CRDMO Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Peptide CRDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Peptide CRDMO Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Peptide CRDMO Market Size by Country (2026-2031) & (US$ Million)
Table 46. Bachem Company Details
Table 47. Bachem Business Overview
Table 48. Bachem Peptide CRDMO Product
Table 49. Bachem Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)
Table 50. Bachem Recent Development
Table 51. PolyPeptide Company Details
Table 52. PolyPeptide Business Overview
Table 53. PolyPeptide Peptide CRDMO Product
Table 54. PolyPeptide Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)
Table 55. PolyPeptide Recent Development
Table 56. Ambio Company Details
Table 57. Ambio Business Overview
Table 58. Ambio Peptide CRDMO Product
Table 59. Ambio Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)
Table 60. Ambio Recent Development
Table 61. USV Peptide Company Details
Table 62. USV Peptide Business Overview
Table 63. USV Peptide Peptide CRDMO Product
Table 64. USV Peptide Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)
Table 65. USV Peptide Recent Development
Table 66. BCNpeptides Company Details
Table 67. BCNpeptides Business Overview
Table 68. BCNpeptides Peptide CRDMO Product
Table 69. BCNpeptides Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)
Table 70. BCNpeptides Recent Development
Table 71. Lonza Company Details
Table 72. Lonza Business Overview
Table 73. Lonza Peptide CRDMO Product
Table 74. Lonza Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)
Table 75. Lonza Recent Development
Table 76. CordenPharma Company Details
Table 77. CordenPharma Business Overview
Table 78. CordenPharma Peptide CRDMO Product
Table 79. CordenPharma Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)
Table 80. CordenPharma Recent Development
Table 81. PeptiDream Company Details
Table 82. PeptiDream Business Overview
Table 83. PeptiDream Peptide CRDMO Product
Table 84. PeptiDream Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)
Table 85. PeptiDream Recent Development
Table 86. AmbioPharm Company Details
Table 87. AmbioPharm Business Overview
Table 88. AmbioPharm Peptide CRDMO Product
Table 89. AmbioPharm Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)
Table 90. AmbioPharm Recent Development
Table 91. CPC Scientific Company Details
Table 92. CPC Scientific Business Overview
Table 93. CPC Scientific Peptide CRDMO Product
Table 94. CPC Scientific Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)
Table 95. CPC Scientific Recent Development
Table 96. Sinopep Company Details
Table 97. Sinopep Business Overview
Table 98. Sinopep Peptide CRDMO Product
Table 99. Sinopep Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)
Table 100. Sinopep Recent Development
Table 101. SynZeal Company Details
Table 102. SynZeal Business Overview
Table 103. SynZeal Peptide CRDMO Product
Table 104. SynZeal Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)
Table 105. SynZeal Recent Development
Table 106. Cambrex Corporation Company Details
Table 107. Cambrex Corporation Business Overview
Table 108. Cambrex Corporation Peptide CRDMO Product
Table 109. Cambrex Corporation Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)
Table 110. Cambrex Corporation Recent Development
Table 111. Tide Pharmaceutical Company Details
Table 112. Tide Pharmaceutical Business Overview
Table 113. Tide Pharmaceutical Peptide CRDMO Product
Table 114. Tide Pharmaceutical Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)
Table 115. Tide Pharmaceutical Recent Development
Table 116. Hybio Pharmaceutical Company Details
Table 117. Hybio Pharmaceutical Business Overview
Table 118. Hybio Pharmaceutical Peptide CRDMO Product
Table 119. Hybio Pharmaceutical Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)
Table 120. Hybio Pharmaceutical Recent Development
Table 121. Rochi Pharma Company Details
Table 122. Rochi Pharma Business Overview
Table 123. Rochi Pharma Peptide CRDMO Product
Table 124. Rochi Pharma Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)
Table 125. Rochi Pharma Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. Peptide CRDMO Picture
Figure 2. Global Peptide CRDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Peptide CRDMO Market Share by Type: 2024 VS 2031
Figure 4. Solid‑Phase Peptide Synthesis Features
Figure 5. Liquid‑Phase Peptide Synthesis Features
Figure 6. Global Peptide CRDMO Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Peptide CRDMO Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceuticals Case Studies
Figure 9. Scientific Research Case Studies
Figure 10. Others Case Studies
Figure 11. Peptide CRDMO Report Years Considered
Figure 12. Global Peptide CRDMO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Peptide CRDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Peptide CRDMO Market Share by Region: 2024 VS 2031
Figure 15. Global Peptide CRDMO Market Share by Players in 2024
Figure 16. Global Peptide CRDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Peptide CRDMO Revenue in 2024
Figure 18. North America Peptide CRDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Peptide CRDMO Market Share by Country (2020-2031)
Figure 20. United States Peptide CRDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Peptide CRDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Peptide CRDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Peptide CRDMO Market Share by Country (2020-2031)
Figure 24. Germany Peptide CRDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Peptide CRDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Peptide CRDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Peptide CRDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Peptide CRDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Ireland Peptide CRDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Peptide CRDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Peptide CRDMO Market Share by Region (2020-2031)
Figure 32. China Peptide CRDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Peptide CRDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Peptide CRDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Peptide CRDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Peptide CRDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia & New Zealand Peptide CRDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Peptide CRDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Peptide CRDMO Market Share by Country (2020-2031)
Figure 40. Mexico Peptide CRDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Peptide CRDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Peptide CRDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Peptide CRDMO Market Share by Country (2020-2031)
Figure 44. Israel Peptide CRDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Peptide CRDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Peptide CRDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Bachem Revenue Growth Rate in Peptide CRDMO Business (2020-2025)
Figure 48. PolyPeptide Revenue Growth Rate in Peptide CRDMO Business (2020-2025)
Figure 49. Ambio Revenue Growth Rate in Peptide CRDMO Business (2020-2025)
Figure 50. USV Peptide Revenue Growth Rate in Peptide CRDMO Business (2020-2025)
Figure 51. BCNpeptides Revenue Growth Rate in Peptide CRDMO Business (2020-2025)
Figure 52. Lonza Revenue Growth Rate in Peptide CRDMO Business (2020-2025)
Figure 53. CordenPharma Revenue Growth Rate in Peptide CRDMO Business (2020-2025)
Figure 54. PeptiDream Revenue Growth Rate in Peptide CRDMO Business (2020-2025)
Figure 55. AmbioPharm Revenue Growth Rate in Peptide CRDMO Business (2020-2025)
Figure 56. CPC Scientific Revenue Growth Rate in Peptide CRDMO Business (2020-2025)
Figure 57. Sinopep Revenue Growth Rate in Peptide CRDMO Business (2020-2025)
Figure 58. SynZeal Revenue Growth Rate in Peptide CRDMO Business (2020-2025)
Figure 59. Cambrex Corporation Revenue Growth Rate in Peptide CRDMO Business (2020-2025)
Figure 60. Tide Pharmaceutical Revenue Growth Rate in Peptide CRDMO Business (2020-2025)
Figure 61. Hybio Pharmaceutical Revenue Growth Rate in Peptide CRDMO Business (2020-2025)
Figure 62. Rochi Pharma Revenue Growth Rate in Peptide CRDMO Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
